128 related articles for article (PubMed ID: 31393173)
21. Treatment of HIV infection in pregnant women: antiretroviral management options.
Loutfy MR; Walmsley SL
Drugs; 2004; 64(5):471-88. PubMed ID: 14977385
[TBL] [Abstract][Full Text] [Related]
22. Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015.
Floridia M; Frisina V; Ravizza M; Marconi AM; Pinnetti C; Cetin I; Sansone M; Molinari A; Cervi F; Meloni A; Luzi K; Masuelli G; Tamburrini E;
J Glob Health; 2017 Jun; 7(1):010407. PubMed ID: 28567279
[TBL] [Abstract][Full Text] [Related]
23. Trends in contraceptive use according to HIV status among privately insured women in the United States.
Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
[TBL] [Abstract][Full Text] [Related]
24. Antiretroviral use during pregnancy for treatment or prophylaxis.
Sturt AS; Read JS
Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
[TBL] [Abstract][Full Text] [Related]
25. Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003.
Kourtis AP; Bansil P; McPheeters M; Meikle SF; Posner SF; Jamieson DJ
AIDS; 2006 Sep; 20(14):1823-31. PubMed ID: 16954723
[TBL] [Abstract][Full Text] [Related]
26. Evaluating HIV/AIDS disparities for blacks in the United States: a review of antiretroviral and mortality studies.
Oramasionwu CU; Brown CM; Lawson KA; Ryan L; Frei CR
J Natl Med Assoc; 2009 Dec; 101(12):1221-9. PubMed ID: 20070010
[TBL] [Abstract][Full Text] [Related]
27. Social Vulnerability among Foreign-Born Pregnant Women and Maternal Virologic Control of HIV.
Premkumar A; Yee LM; Benes L; Miller ES
Am J Perinatol; 2021 Jul; 38(8):753-758. PubMed ID: 33368072
[TBL] [Abstract][Full Text] [Related]
28. The relationship of pregnancy to the use of highly active antiretroviral therapy.
Minkoff H; Ahdieh L; Watts H; Greenblatt RM; Schmidt J; Schneider M; Stek A
Am J Obstet Gynecol; 2001 May; 184(6):1221-7. PubMed ID: 11349192
[TBL] [Abstract][Full Text] [Related]
29. Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review.
Premkumar A; Dude AM; Haddad LB; Yee LM
Pregnancy Hypertens; 2019 Jul; 17():178-190. PubMed ID: 31487638
[TBL] [Abstract][Full Text] [Related]
30. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
Omonaiye O; Kusljic S; Nicholson P; Manias E
BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
[TBL] [Abstract][Full Text] [Related]
31. Racial/ethnic disparities among children with diagnoses of perinatal HIV infection - 34 states, 2004-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Feb; 59(4):97-101. PubMed ID: 20134398
[TBL] [Abstract][Full Text] [Related]
32. Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy.
Bukkems VE; Smolders EJ; Jourdain G; Burger DM; Colbers AP; Cressey TR;
J Clin Pharmacol; 2021 Mar; 61(3):388-393. PubMed ID: 32960984
[TBL] [Abstract][Full Text] [Related]
33. Impact of Extended Combination Antiretroviral Therapy on the Decline of HIV Prevalence in Pregnant Women in Malawi.
Liotta G; Chimbwandira F; Wouters K; Nielsen-Saines K; Jere H; Mancinelli S; Ceffa S; Erba F; Palombi L; Marazzi MC
J Int Assoc Provid AIDS Care; 2016; 15(2):172-7. PubMed ID: 26512040
[TBL] [Abstract][Full Text] [Related]
34. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.
Hall HI; Frazier EL; Rhodes P; Holtgrave DR; Furlow-Parmley C; Tang T; Gray KM; Cohen SM; Mermin J; Skarbinski J
JAMA Intern Med; 2013 Jul; 173(14):1337-44. PubMed ID: 23780395
[TBL] [Abstract][Full Text] [Related]
35. Screening for HIV in pregnant women: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.
Chou R; Cantor AG; Zakher B; Bougatsos C
Ann Intern Med; 2012 Nov; 157(10):719-28. PubMed ID: 23165663
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania.
Nyombi BM; Holm-Hansen C; Kristiansen KI; Bjune G; Müller F
AIDS Res Ther; 2008 Jun; 5():13. PubMed ID: 18570675
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
Fatti G; Shaikh N; Eley B; Grimwood A
AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
[TBL] [Abstract][Full Text] [Related]
38. Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study.
Myer L; Zulliger R; Bekker LG; Abrams E
BMC Pregnancy Childbirth; 2012 Sep; 12():94. PubMed ID: 22963318
[TBL] [Abstract][Full Text] [Related]
39. Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART.
Cocohoba JM; Althoff KN; Godfrey R; Palella FJ; Greenblatt RM
AIDS Care; 2012; 24(1):20-9. PubMed ID: 21732716
[TBL] [Abstract][Full Text] [Related]
40. Micronutrient supplementation in pregnant women with HIV infection.
Siegfried N; Irlam JH; Visser ME; Rollins NN
Cochrane Database Syst Rev; 2012 Mar; (3):CD009755. PubMed ID: 22419344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
